BioCentury | Mar 28, 2021
Finance

Launched by Pharmacyclics vets, preclinical cancer start-up Biomea Fusion seeks short path to IPO

...Chemistry Thorsten Kirschberg, a longtime Gilead Sciences Inc. (NASDAQ:GILD) employee who was most recently at Terns Pharmaceuticals Inc....
BioCentury | Feb 2, 2021
Finance

Sana among 10 biotechs set to flood market for IPOs

...session, with four more biotechs due to trade on Friday: Immunocore Ltd., Sensei Biotherapeutics Inc., Terns Pharmaceuticals Inc....
BioCentury | Jan 20, 2021
Finance

IPO queue upswelling: Data Byte

...companies are seeking a listing on NASDAQ. Winnie Pong Lucira Health Inc. LumiraDx Ltd. Angion Biomedica Corp. Immunocore Holdings Ltd. Pharvaris N.V. Terns Pharmaceuticals Inc. Bolt...
BioCentury | Jan 5, 2021
Finance

Immuneering, Terns, Ikena raise crossover rounds as IPO queue stands to grow again

...close was in January 2020.Liver disease company Terns Pharmaceuticals Inc....
...TEA domainTHRB - Thyroid hormone receptor β Paul Bonanos Terns Pharmaceuticals Inc. Immuneering...
BioCentury | Oct 1, 2020
Management Tracks

CVS’s Asgarian joins Thrive as CMO; plus Black Diamond names Ingram chairman and updates from MorphoSys, G1 and more

...where he was global VP and GM of China; Li was most recently CFO of Terns Pharmaceuticals Inc. California...
BioCentury | Aug 29, 2020
Emerging Company Profile

Arctic Vision sets sights on China’s innovation gap in ophthalmology

...input from outside China, and a lack of in-house incubation,” Wu said.Wu left liver diseases company Terns Pharmaceuticals Inc....
BioCentury | Aug 13, 2020
Management Tracks

NHC’s Boutin to head patient advocacy at Novartis; plus changes at Moderna, PIC, Atea, Terns, NBE and Omega

...to treat COVID-19 (see “Atea Draws $215M as it Preps Phase II COVID-19 Trial”).On Monday, Terns Pharmaceuticals Inc....
...2017, Omega has raised $85 million to develop therapies targeting chromatin structures. Robin Sawka Atea Pharmaceuticals Inc. Moderna Inc. Terns Pharmaceuticals Inc. NBE-Therapeutics...
BioCentury | Jul 1, 2019
Company News

Management Tracks: BioCryst hires its first CBO; plus ObsEva, Veracyte and more

...out last year from the MedImmune LLC subsidiary of AstraZeneca plc (LSE:AZN; NYSE:AZN). NASH company Terns Pharmaceuticals Inc....
...FDA Commissioner" ). Mary Romeo, Assistant Editor Sio Gene Therapies Inc. BioCryst Pharmaceuticals Inc. Nanobiotix S.A. National Cancer Institute ObsEva S.A. Squarex LLC Terns Pharmaceuticals Inc. Veracyte...
BioCentury | Jun 24, 2019
Company News

June 24 Company Quick Takes: Terns gains Chinese rights to elafibranor; plus venetoclax, Zejula and more

...Terns gets Chinese rights to Genfit's liver disease candidate Terns Pharmaceuticals Inc. (San Mateo, Calif.) licensed rights to...
...ZL-2306 (Compound #), MK-4827 (Compound #), niraparib (Generic), Zejula (Informal) AbbVie Inc. Evotec SE Genfit S.A. GlaxoSmithKline plc Sensyne Health plc Terns Pharmaceuticals Inc. University...
BioCentury | Jan 17, 2019
Company News

Management tracks: eGenesis names Sekhri CEO

...was VP and head, global commercial strategy and marketing oncology at Gilead Sciences Inc. (NASDAQ:GILD). Terns Pharmaceuticals Inc....
Items per page:
1 - 10 of 15
BioCentury | Mar 28, 2021
Finance

Launched by Pharmacyclics vets, preclinical cancer start-up Biomea Fusion seeks short path to IPO

...Chemistry Thorsten Kirschberg, a longtime Gilead Sciences Inc. (NASDAQ:GILD) employee who was most recently at Terns Pharmaceuticals Inc....
BioCentury | Feb 2, 2021
Finance

Sana among 10 biotechs set to flood market for IPOs

...session, with four more biotechs due to trade on Friday: Immunocore Ltd., Sensei Biotherapeutics Inc., Terns Pharmaceuticals Inc....
BioCentury | Jan 20, 2021
Finance

IPO queue upswelling: Data Byte

...companies are seeking a listing on NASDAQ. Winnie Pong Lucira Health Inc. LumiraDx Ltd. Angion Biomedica Corp. Immunocore Holdings Ltd. Pharvaris N.V. Terns Pharmaceuticals Inc. Bolt...
BioCentury | Jan 5, 2021
Finance

Immuneering, Terns, Ikena raise crossover rounds as IPO queue stands to grow again

...close was in January 2020.Liver disease company Terns Pharmaceuticals Inc....
...TEA domainTHRB - Thyroid hormone receptor β Paul Bonanos Terns Pharmaceuticals Inc. Immuneering...
BioCentury | Oct 1, 2020
Management Tracks

CVS’s Asgarian joins Thrive as CMO; plus Black Diamond names Ingram chairman and updates from MorphoSys, G1 and more

...where he was global VP and GM of China; Li was most recently CFO of Terns Pharmaceuticals Inc. California...
BioCentury | Aug 29, 2020
Emerging Company Profile

Arctic Vision sets sights on China’s innovation gap in ophthalmology

...input from outside China, and a lack of in-house incubation,” Wu said.Wu left liver diseases company Terns Pharmaceuticals Inc....
BioCentury | Aug 13, 2020
Management Tracks

NHC’s Boutin to head patient advocacy at Novartis; plus changes at Moderna, PIC, Atea, Terns, NBE and Omega

...to treat COVID-19 (see “Atea Draws $215M as it Preps Phase II COVID-19 Trial”).On Monday, Terns Pharmaceuticals Inc....
...2017, Omega has raised $85 million to develop therapies targeting chromatin structures. Robin Sawka Atea Pharmaceuticals Inc. Moderna Inc. Terns Pharmaceuticals Inc. NBE-Therapeutics...
BioCentury | Jul 1, 2019
Company News

Management Tracks: BioCryst hires its first CBO; plus ObsEva, Veracyte and more

...out last year from the MedImmune LLC subsidiary of AstraZeneca plc (LSE:AZN; NYSE:AZN). NASH company Terns Pharmaceuticals Inc....
...FDA Commissioner" ). Mary Romeo, Assistant Editor Sio Gene Therapies Inc. BioCryst Pharmaceuticals Inc. Nanobiotix S.A. National Cancer Institute ObsEva S.A. Squarex LLC Terns Pharmaceuticals Inc. Veracyte...
BioCentury | Jun 24, 2019
Company News

June 24 Company Quick Takes: Terns gains Chinese rights to elafibranor; plus venetoclax, Zejula and more

...Terns gets Chinese rights to Genfit's liver disease candidate Terns Pharmaceuticals Inc. (San Mateo, Calif.) licensed rights to...
...ZL-2306 (Compound #), MK-4827 (Compound #), niraparib (Generic), Zejula (Informal) AbbVie Inc. Evotec SE Genfit S.A. GlaxoSmithKline plc Sensyne Health plc Terns Pharmaceuticals Inc. University...
BioCentury | Jan 17, 2019
Company News

Management tracks: eGenesis names Sekhri CEO

...was VP and head, global commercial strategy and marketing oncology at Gilead Sciences Inc. (NASDAQ:GILD). Terns Pharmaceuticals Inc....
Items per page:
1 - 10 of 15